Some US hospitals have turned down part of their allocation of remdesivir, the anti-COVID-19 drug manufactured through Gilead Sciences, the US Health and Human Services Decomponent showed on Friday.
From July 6 to September 8, state and territorial public fitness systems accepted about 72% of the remdesivir presented to them through HHS, a spokesperson to Reuters showed a spokesman for Reuters on Friday. The hospitals then bought about two-thirds of what the states and territories accepted.
The government has led the distribution of the drug, but that effort expires at the end of the month, and some hospitals are storing repobreza because they do not know what the drug will be obtained after September and must be ready if the pandemic erupts this winter. Galaad did not respond to a request for comment from Reuters.
The hospital says its pharmaceutical materials are good enough in components because they only use them to treat the sickest patients, even though the Food and Drug Administration (FDA) is respectful of their use in more cases.
Dr. Adarsh Bhimraj, an infectious disease specialist at the Cleveland Clinic, said he was skeptical about the use of remdesivir in patients with moderate COVID-19, especially given the price.
The resulting surplus of repopulation, which costs $3,120 for an intravenous cure of six vials, contrasts with the early days of the pandemic, when the new drug was scarce in some areas. For the first time since mid-March, Canada spent 24 hours without reporting a COVID-19 death, according to the public fitness firm’s knowledge published Friday night.
Canada has 9214 COVID-19 deaths and 137676 showed cases of coronavirus disease on Friday, according to knowledge from Johns Hopkins University.
Most of the country’s provinces are relaxing their pandemic restrictions and schools are opening face-to-face courses, leading to a slight increase in infections in recent days. Virus.
Health officials say Canada’s delight with SARS, or severe acute respiratory syndrome, has helped them be more prepared. SARS killed 44 other people in Canada, Asia’s only open-air country to report deaths from the outbreak in 2002 and 2003. The first case of coronavirus recorded in Canada occurred in Toronto on January 25.
India recorded nearly 100,000 new cases of COVID-19 in one day on Thursday. The South Asian country said Friday that there had been 96,551 new cases in the last 24 hours. India has a total of 4. 5 million cases of COVID.
With more than 6. 4 million infections, the United States is the only country with the most COVID infections than India. In the United States, COVID-19 cases are “increasingly immediate in young adults,” according to a letter from Harvard studies, published online in the medical journal JAMA.
The study included 3,222 young adults between the age of 18 and 34. The survey found that young adults “experienced very high rates of adverse outcomes: 21% required intensive care, 10% required mechanical ventilation and 2. 7% died. “
Patients with morbid obesity, high blood pressure and diabetes had “an increased threat of adverse events. “Young adults with more than one of these conditions found the researchers, “faced threats comparable to those seen in middle-aged adults without them. “Black and Hispanic patients accounted for more than part of the patients who had to be hospitalized.
A separate report from the Centers for Disease Control and Prevention indicates that a survey of symptomatic outpatients from 11 U. S. fitness services is a U. S. patient survey. But it’s not the first time He found that other people who tested positive for COVID-19 were twice as likely to have reported eating at a place to eat than those who tested negative.
Johns Hopkins University reports that there are more than 28 million international COVID-19 with more than 913,000 deaths.